BiotechTube
HTL Biotechnology

HTL Biotechnology

Saint-Jean-de-Védas, France· Est.
htlbiotech.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $15M

Overview

HTL Biotechnology is a private, specialty biopolymer company based near Montpellier, France. It has developed a proprietary platform for the sustainable manufacturing of ultra-pure, pharmaceutical-grade biopolymers, which serve as essential excipients and matrices in advanced therapeutics and regenerative medicine. While not a traditional therapeutic developer, its products are enabling components for partners in the biologics and cell therapy spaces, suggesting a B2B platform and services model. The company is likely in a revenue-generating stage, supplying key materials to the pharmaceutical industry.

Drug DeliveryRegenerative MedicineMedical Devices

Technology Platform

Proprietary platform for the sustainable fermentation, modification, and purification of pharmaceutical-grade biopolymers, notably hyaluronic acid and its derivatives, for use as enabling components in therapeutics and medical products.

Funding History

1
Total raised:$15M
Debt$15M

Opportunities

The rapid growth of biologics, cell, and gene therapies drives demand for advanced formulation and delivery materials.
The industry shift towards sustainable, animal-free, and traceable raw materials aligns perfectly with HTL's fermentation-based production platform.
There is significant potential to develop novel, proprietary polymer derivatives for high-value applications in targeted drug delivery and regenerative medicine.

Risk Factors

Revenue is dependent on the clinical and commercial success of partner companies, creating significant downstream risk.
The company faces competition from large chemical suppliers and potential commoditization of standard biopolymer grades.
Maintaining stringent quality control and regulatory compliance as a critical pharmaceutical supplier presents an ongoing operational and financial challenge.

Competitive Landscape

HTL competes in the pharmaceutical biopolymer market against large diversified players like Galderma (Restylane), Contipro, and Bloomage Bio, as well as divisions of major chemical companies. Its differentiation is based on a focused pharmaceutical-grade strategy, sustainability narrative, and custom development capabilities, rather than competing primarily on volume or price in the cosmetic-grade market.

More companies in Biologics / Biosimilars →More companies in France →